PT89123A - Metodo para a utilizacao de d1-5-{(2-benzil-3,4-di-hidro-2h-benzopiran-6-il)metil}tiazolidino-2,4-diona como agente anti-aterosclerose - Google Patents

Metodo para a utilizacao de d1-5-{(2-benzil-3,4-di-hidro-2h-benzopiran-6-il)metil}tiazolidino-2,4-diona como agente anti-aterosclerose

Info

Publication number
PT89123A
PT89123A PT89123A PT8912388A PT89123A PT 89123 A PT89123 A PT 89123A PT 89123 A PT89123 A PT 89123A PT 8912388 A PT8912388 A PT 8912388A PT 89123 A PT89123 A PT 89123A
Authority
PT
Portugal
Prior art keywords
thiazolidine
benzopyran
dihydro
benzyl
methyl
Prior art date
Application number
PT89123A
Other languages
English (en)
Other versions
PT89123B (pt
Inventor
Michael Norman Krupp
Archie Calhoun Swindell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT89123A publication Critical patent/PT89123A/pt
Publication of PT89123B publication Critical patent/PT89123B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT89123A 1987-12-02 1988-11-30 Metodo para a utilizacao de d1-5-{(2-benzil-3,4-di-hidro-2h-benzopiran-6-il)metil}tiazolidino-2,4-diona como agente anti-aterosclerose PT89123B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/127,858 US4798835A (en) 1987-12-02 1987-12-02 dl-5-[(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl]thiazolidine-2,4-dione as an anti-atherosclerosis agent

Publications (2)

Publication Number Publication Date
PT89123A true PT89123A (pt) 1989-12-29
PT89123B PT89123B (pt) 1993-09-30

Family

ID=22432331

Family Applications (1)

Application Number Title Priority Date Filing Date
PT89123A PT89123B (pt) 1987-12-02 1988-11-30 Metodo para a utilizacao de d1-5-{(2-benzil-3,4-di-hidro-2h-benzopiran-6-il)metil}tiazolidino-2,4-diona como agente anti-aterosclerose

Country Status (16)

Country Link
US (1) US4798835A (pt)
EP (1) EP0319288B1 (pt)
JP (1) JPH01186883A (pt)
KR (1) KR900006993B1 (pt)
AT (1) ATE81456T1 (pt)
AU (1) AU604176B2 (pt)
CA (1) CA1313139C (pt)
DE (1) DE3875324T2 (pt)
DK (1) DK670988A (pt)
HU (1) HU204433B (pt)
IE (1) IE883600L (pt)
IL (1) IL88513A (pt)
MY (1) MY103498A (pt)
PH (1) PH24873A (pt)
PT (1) PT89123B (pt)
ZA (1) ZA888968B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053420A (en) * 1989-10-13 1991-10-01 Pershadsingh Harrihar A Thiazolidine derivatives for the treatment of hypertension
EP0715853A1 (en) * 1991-01-10 1996-06-12 Transcend Therapeutics, Inc. Use of glutathione esters for the treatment of pulmonary diseases
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5866595A (en) * 1991-09-26 1999-02-02 The Regents Of The University Of California Calcium antagonists for treatment of vascular restenosis
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5306724A (en) * 1992-08-17 1994-04-26 Clintec Nutrition Company Method for preventing and treating atherosclerosis
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
GB9611947D0 (en) * 1996-06-07 1996-08-07 Glaxo Group Ltd Medicaments

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS58118577A (ja) * 1982-01-07 1983-07-14 Takeda Chem Ind Ltd チアゾリジン誘導体
US4617312A (en) * 1983-01-17 1986-10-14 Pfizer Inc. Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinediones
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
HU210339B (en) * 1985-05-21 1995-03-28 Pfizer Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物

Also Published As

Publication number Publication date
MY103498A (en) 1993-06-30
ATE81456T1 (de) 1992-10-15
IL88513A (en) 1994-04-12
US4798835A (en) 1989-01-17
IL88513A0 (en) 1989-06-30
DE3875324D1 (de) 1992-11-19
DK670988D0 (da) 1988-12-01
KR890009922A (ko) 1989-08-04
DK670988A (da) 1989-07-24
EP0319288A3 (en) 1990-12-27
ZA888968B (en) 1990-07-25
KR900006993B1 (ko) 1990-09-25
JPH0460582B2 (pt) 1992-09-28
DE3875324T2 (de) 1993-02-25
IE883600L (en) 1989-06-02
EP0319288A2 (en) 1989-06-07
AU604176B2 (en) 1990-12-06
HUT54045A (en) 1991-01-28
AU2647188A (en) 1989-06-08
CA1313139C (en) 1993-01-26
PH24873A (en) 1990-12-26
JPH01186883A (ja) 1989-07-26
PT89123B (pt) 1993-09-30
HU204433B (en) 1992-01-28
EP0319288B1 (en) 1992-10-14

Similar Documents

Publication Publication Date Title
MX9203808A (es) Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
FI872756A (fi) Med laserstraolning fungerande terapeutisk anordning.
NO871408D0 (no) Forbedringer ved farmasoeytiske akseptable salter.
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
BR9914631A (pt) Composição imunológica oral indutora de tolerância para prevenção e/ou tratamento de enfermidades e método para prevenção e/ou tratamento de enfermidades
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
ES2160410T3 (es) Preparados de complejos de protrombina inmunotolerantes.
PT89123A (pt) Metodo para a utilizacao de d1-5-{(2-benzil-3,4-di-hidro-2h-benzopiran-6-il)metil}tiazolidino-2,4-diona como agente anti-aterosclerose
KR880013555A (ko) 당뇨병의 치료방법
PT87197A (pt) Processo para preparacao de agentes terapeuticos eritropoietina
SE8500996D0 (sv) Method of treatment
NO881768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
ES2032797T3 (es) Agente terapeutico para el tratamiento de la enfermedad ulcera peptica.
DK0378146T3 (da) Polyamin-derivater som antineoplastiske midler
NO905327D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbamoylderivater.
FI93725B (fi) Menetelmä optisesti aktiivisten, oikealle kiertävien okso-isoindolinyylijohdannaisten valmistamiseksi
NO980564L (no) Sulfonamid-substituerte forbindelser, fremgangsmÕte for fremstilling, anvendelse som medikament eller diagnostikum samt oppnÕdd medikament er beskrevet
IT8026232A0 (it) Composizioni farmaceutiche. derivato dell'alfa-mercapto propionilglicina ad attivita'terapeutica, procedimento per lasua preparazione e relative
KR880009653A (ko) 혈액중 요산농도를 감소시키는데 유용한 치료제
NO167800C (no) Mellomprodukt for fremstilling av terapeutisk aktiv 1-cyklopropyl-6-fluor-1,4-dihydro-4-okso-7-piperazino-kinolin-3-karboksylsyre.
ITFI940190A0 (it) Attrezzo per il potenziamento dell'attivita' circolatoria venosa, specialmente delle gambe
NO880051D0 (no) Tipp-beholder for kjoeretoey, fortrinnsvis skinnegaaende kjoeretoey.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19930305

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19940930